{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:23:58Z","timestamp":1790821438860,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00261-019-02044-w","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T07:14:34Z","timestamp":1557299674000},"page":"928-944","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Genetics and imaging of pheochromocytomas and paragangliomas: current update"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7800-7312","authenticated-orcid":false,"given":"Venkata S.","family":"Katabathina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Rajebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos S.","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umber","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghu","family":"Vikram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine O.","family":"Menias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasa R.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"issue":"6","key":"2044_CR1","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.beem.2010.05.001","volume":"24","author":"G Opocher","year":"2010","unstructured":"Opocher G, Schiavi F (2010) Genetics of pheochromocytomas and paragangliomas. Best practice & research Clinical endocrinology & metabolism 24 (6):943-956. \nhttps:\/\/doi.org\/10.1016\/j.beem.2010.05.001","journal-title":"Best practice & research Clinical endocrinology & metabolism"},{"issue":"1","key":"2044_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.hoc.2015.09.006","volume":"30","author":"L Fishbein","year":"2016","unstructured":"Fishbein L (2016) Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment. Hematol Oncol Clin North Am 30 (1):135-150. \nhttps:\/\/doi.org\/10.1016\/j.hoc.2015.09.006","journal-title":"Hematol Oncol Clin North Am"},{"key":"2044_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3389\/fendo.2018.00515","volume":"9","author":"R Alrezk","year":"2018","unstructured":"Alrezk R, Suarez A, Tena I, Pacak K (2018) Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging. Front Endocrinol (Lausanne) 9:515. \nhttps:\/\/doi.org\/10.3389\/fendo.2018.00515","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2044_CR4","doi-asserted-by":"publisher","unstructured":"Lam AK (2017) Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours. Endocr Pathol. doi:\nhttps:\/\/doi.org\/10.1007\/s12022-017-9484-5","DOI":"10.1007\/s12022-017-9484-5"},{"key":"2044_CR5","unstructured":"DeLellis R (2004) Pathology and genetics of tumours of endocrine organs. World Health Organization classification of tumours. Lyon, France: IARC Press; 2004."},{"issue":"1","key":"2044_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4158\/EP-2017-0057","volume":"24","author":"LB Mercado-Asis","year":"2018","unstructured":"Mercado-Asis LB, Wolf KI, Jochmanova I, Taieb D (2018) Pheochromocytoma: A Genetic and Diagnostic Update. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 24 (1):78-90. \nhttps:\/\/doi.org\/10.4158\/EP-2017-0057","journal-title":"Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists"},{"key":"2044_CR7","unstructured":"Lloyd RV (2017) WHO classification of tumours of endocrine organs. Lyon, France: IARC; 2017"},{"issue":"2","key":"2044_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrc3648","volume":"14","author":"PL Dahia","year":"2014","unstructured":"Dahia PL (2014) Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nature reviews Cancer 14 (2):108-119. \nhttps:\/\/doi.org\/10.1038\/nrc3648","journal-title":"Nature reviews Cancer"},{"issue":"6","key":"2044_CR9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/er.2017-00062","volume":"38","author":"J Crona","year":"2017","unstructured":"Crona J, Taieb D, Pacak K (2017) New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification. Endocr Rev 38 (6):489-515. \nhttps:\/\/doi.org\/10.1210\/er.2017-00062","journal-title":"Endocr Rev"},{"issue":"1","key":"2044_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12022-012-9199-6","volume":"23","author":"S Nolting","year":"2012","unstructured":"Nolting S, Grossman AB (2012) Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies. Endocrine pathology 23 (1):21-33. \nhttps:\/\/doi.org\/10.1007\/s12022-012-9199-6","journal-title":"Endocrine pathology"},{"issue":"2","key":"2044_CR11","first-page":"141","volume":"37","author":"U Shah","year":"2012","unstructured":"Shah U, Giubellino A, Pacak K (2012) Pheochromocytoma: implications in tumorigenesis and the actual management. Minerva endocrinologica 37 (2):141-156","journal-title":"Minerva endocrinologica"},{"key":"2044_CR12","doi-asserted-by":"publisher","unstructured":"Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, Lichtenberg TM, Murray BA, Ghayee HK, Else T, Ling S, Jefferys SR, de Cubas AA, Wenz B, Korpershoek E, Amelio AL, Makowski L, Rathmell WK, Gimenez-Roqueplo AP, Giordano TJ, Asa SL, Tischler AS, Cancer Genome Atlas Research N, Pacak K, Nathanson KL, Wilkerson MD (2017) Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer cell 31 (2):181-193. \nhttps:\/\/doi.org\/10.1016\/j.ccell.2017.01.001","DOI":"10.1016\/j.ccell.2017.01.001"},{"issue":"11","key":"2044_CR13","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1093\/hmg\/ddt069","volume":"22","author":"I Comino-Mendez","year":"2013","unstructured":"Comino-Mendez I, de Cubas AA, Bernal C, Alvarez-Escola C, Sanchez-Malo C, Ramirez-Tortosa CL, Pedrinaci S, Rapizzi E, Ercolino T, Bernini G, Bacca A, Leton R, Pita G, Alonso MR, Leandro-Garcia LJ, Gomez-Grana A, Inglada-Perez L, Mancikova V, Rodriguez-Antona C, Mannelli M, Robledo M, Cascon A (2013) Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis. Human molecular genetics 22 (11):2169-2176. \nhttps:\/\/doi.org\/10.1093\/hmg\/ddt069","journal-title":"Human molecular genetics"},{"issue":"2","key":"2044_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/cen.12071","volume":"78","author":"SR Galan","year":"2013","unstructured":"Galan SR, Kann PH (2013) Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma. Clinical endocrinology 78 (2):165-175. \nhttps:\/\/doi.org\/10.1111\/cen.12071","journal-title":"Clinical endocrinology"},{"issue":"2","key":"2044_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00441-018-2791-4","volume":"372","author":"D Taieb","year":"2018","unstructured":"Taieb D, Pacak K (2018) Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma. Cell Tissue Res 372 (2):393-401. \nhttps:\/\/doi.org\/10.1007\/s00441-018-2791-4","journal-title":"Cell Tissue Res"},{"issue":"Suppl 1","key":"2044_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0959-8049(09)70041-3","volume":"45","author":"K Frank-Raue","year":"2009","unstructured":"Frank-Raue K, Raue F (2009) Multiple endocrine neoplasia type 2 (MEN 2). Eur J Cancer 45 Suppl 1:267-273. \nhttps:\/\/doi.org\/10.1016\/S0959-8049(09)70041-3","journal-title":"Eur J Cancer"},{"issue":"3","key":"2044_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.beem.2010.02.001","volume":"24","author":"N Wohllk","year":"2010","unstructured":"Wohllk N, Schweizer H, Erlic Z, Schmid KW, Walz MK, Raue F, Neumann HP (2010) Multiple endocrine neoplasia type 2. Best practice & research Clinical endocrinology & metabolism 24 (3):371-387. \nhttps:\/\/doi.org\/10.1016\/j.beem.2010.02.001","journal-title":"Best practice & research Clinical endocrinology & metabolism"},{"issue":"6","key":"2044_CR18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"Wells SA, Jr., Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG, American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma (2015) Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25 (6):567-610. \nhttps:\/\/doi.org\/10.1089\/thy.2014.0335","journal-title":"Thyroid"},{"issue":"5","key":"2044_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00403-010-1090-z","volume":"303","author":"L Zinnamosca","year":"2011","unstructured":"Zinnamosca L, Petramala L, Cotesta D, Marinelli C, Schina M, Cianci R, Giustini S, Sciomer S, Anastasi E, Calvieri S, De Toma G, Letizia C (2011) Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects. Arch Dermatol Res 303 (5):317-325. \nhttps:\/\/doi.org\/10.1007\/s00403-010-1090-z","journal-title":"Arch Dermatol Res"},{"key":"2044_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1477-7819-8-14","volume":"8","author":"GN Zografos","year":"2010","unstructured":"Zografos GN, Vasiliadis GK, Zagouri F, Aggeli C, Korkolis D, Vogiaki S, Pagoni MK, Kaltsas G, Piaditis G (2010) Pheochromocytoma associated with neurofibromatosis type 1: concepts and current trends. World journal of surgical oncology 8:14. \nhttps:\/\/doi.org\/10.1186\/1477-7819-8-14","journal-title":"World journal of surgical oncology"},{"issue":"2","key":"2044_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1530\/eje-11-0497","volume":"166","author":"M Jafri","year":"2012","unstructured":"Jafri M, Maher ER (2012) The genetics of phaeochromocytoma: using clinical features to guide genetic testing. European journal of endocrinology \/ European Federation of Endocrine Societies 166 (2):151-158. \nhttps:\/\/doi.org\/10.1530\/eje-11-0497","journal-title":"European journal of endocrinology \/ European Federation of Endocrine Societies"},{"issue":"1","key":"2044_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1542\/peds.2007-3204","volume":"123","author":"VC Williams","year":"2009","unstructured":"Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL (2009) Neurofibromatosis type 1 revisited. Pediatrics 123 (1):124-133. \nhttps:\/\/doi.org\/10.1542\/peds.2007-3204","journal-title":"Pediatrics"},{"issue":"6","key":"2044_CR23","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/ejhg.2010.175","volume":"19","author":"ER Maher","year":"2011","unstructured":"Maher ER, Neumann HP, Richard S (2011) von Hippel-Lindau disease: a clinical and scientific review. European journal of human genetics : EJHG 19(6):617-623. \nhttps:\/\/doi.org\/10.1038\/ejhg.2010.175","journal-title":"European journal of human genetics : EJHG"},{"issue":"6","key":"2044_CR24","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s11906-010-0151-1","volume":"12","author":"D Karasek","year":"2010","unstructured":"Karasek D, Frysak Z, Pacak K (2010) Genetic testing for pheochromocytoma. Current hypertension reports 12(6):456-464. \nhttps:\/\/doi.org\/10.1007\/s11906-010-0151-1","journal-title":"Current hypertension reports"},{"issue":"3","key":"2044_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.beem.2010.04.001","volume":"24","author":"V Kantorovich","year":"2010","unstructured":"Kantorovich V, King KS, Pacak K (2010) SDH-related pheochromocytoma and paraganglioma. Best practice & research Clinical endocrinology & metabolism 24 (3):415-424. \nhttps:\/\/doi.org\/10.1016\/j.beem.2010.04.001","journal-title":"Best practice & research Clinical endocrinology & metabolism"},{"key":"2044_CR26","doi-asserted-by":"publisher","unstructured":"Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C, European-American Paraganglioma Study Group (2004) Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292 (8):943-951. \nhttps:\/\/doi.org\/10.1001\/jama.292.8.943","DOI":"10.1001\/jama.292.8.943"},{"issue":"4","key":"2044_CR27","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s13244-011-0096-1","volume":"2","author":"B Barber","year":"2011","unstructured":"Barber B, Ingram M, Khan S, Bano G, Hodgson S, Vlahos I (2011) Clinicoradiological manifestations of paraganglioma syndromes associated with succinyl dehydrogenase enzyme mutation. Insights into imaging 2 (4):431-438. \nhttps:\/\/doi.org\/10.1007\/s13244-011-0096-1","journal-title":"Insights into imaging"},{"issue":"8","key":"2044_CR28","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/gim.2014.162","volume":"17","author":"L Evenepoel","year":"2015","unstructured":"Evenepoel L, Papathomas TG, Krol N, Korpershoek E, de Krijger RR, Persu A, Dinjens WN (2015) Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations. Genet Med 17 (8):610-620. \nhttps:\/\/doi.org\/10.1038\/gim.2014.162","journal-title":"Genet Med"},{"issue":"3","key":"2044_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10689-010-9323-z","volume":"9","author":"I Alrashdi","year":"2010","unstructured":"Alrashdi I, Bano G, Maher ER, Hodgson SV (2010) Carney triad versus Carney Stratakis syndrome: two cases which illustrate the difficulty in distinguishing between these conditions in individual patients. Familial cancer 9 (3):443-447. \nhttps:\/\/doi.org\/10.1007\/s10689-010-9323-z","journal-title":"Familial cancer"},{"issue":"1","key":"2044_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.ejhg.5201904","volume":"16","author":"B Pasini","year":"2008","unstructured":"Pasini B, McWhinney SR, Bei T, Matyakhina L, Stergiopoulos S, Muchow M, Boikos SA, Ferrando B, Pacak K, Assie G, Baudin E, Chompret A, Ellison JW, Briere JJ, Rustin P, Gimenez-Roqueplo AP, Eng C, Carney JA, Stratakis CA (2008) Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. European journal of human genetics : EJHG 16 (1):79-88. \nhttps:\/\/doi.org\/10.1038\/sj.ejhg.5201904","journal-title":"European journal of human genetics : EJHG"},{"issue":"8","key":"2044_CR31","doi-asserted-by":"publisher","first-page":"E1279","DOI":"10.1210\/jc.2011-0114","volume":"96","author":"HP Neumann","year":"2011","unstructured":"Neumann HP, Sullivan M, Winter A, Malinoc A, Hoffmann MM, Boedeker CC, Bertz H, Walz MK, Moeller LC, Schmid KW, Eng C (2011) Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites. The Journal of clinical endocrinology and metabolism 96(8):E1279-1282. \nhttps:\/\/doi.org\/10.1210\/jc.2011-0114","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"10","key":"2044_CR32","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","volume":"18","author":"N Burnichon","year":"2012","unstructured":"Burnichon N, Cascon A, Schiavi F, Morales NP, Comino-Mendez I, Abermil N, Inglada-Perez L, de Cubas AA, Amar L, Barontini M, de Quiros SB, Bertherat J, Bignon YJ, Blok MJ, Bobisse S, Borrego S, Castellano M, Chanson P, Chiara MD, Corssmit EP, Giacche M, de Krijger RR, Ercolino T, Girerd X, Gomez-Garcia EB, Gomez-Grana A, Guilhem I, Hes FJ, Honrado E, Korpershoek E, Lenders JW, Leton R, Mensenkamp AR, Merlo A, Mori L, Murat A, Pierre P, Plouin PF, Prodanov T, Quesada-Charneco M, Qin N, Rapizzi E, Raymond V, Reisch N, Roncador G, Ruiz-Ferrer M, Schillo F, Stegmann AP, Suarez C, Taschin E, Timmers HJ, Tops CM, Urioste M, Beuschlein F, Pacak K, Mannelli M, Dahia PL, Opocher G, Eisenhofer G, Gimenez-Roqueplo AP, Robledo M (2012) MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin Cancer Res 18(10):2828-2837. \nhttps:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0160","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2044_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrendo.2014.188","volume":"11","author":"J Favier","year":"2015","unstructured":"Favier J, Amar L, Gimenez-Roqueplo AP (2015) Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nat Rev Endocrinol 11(2):101-111. \nhttps:\/\/doi.org\/10.1038\/nrendo.2014.188","journal-title":"Nat Rev Endocrinol"},{"issue":"Suppl 1","key":"2044_CR34","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1148\/rg.24si045506","volume":"24","author":"MA Blake","year":"2004","unstructured":"Blake MA, Kalra MK, Maher MM, Sahani DV, Sweeney AT, Mueller PR, Hahn PF, Boland GW (2004) Pheochromocytoma: an imaging chameleon. Radiographics 24(Suppl 1):S87-99. \nhttps:\/\/doi.org\/10.1148\/rg.24si045506","journal-title":"Radiographics"},{"issue":"2","key":"2044_CR35","doi-asserted-by":"publisher","first-page":"370","DOI":"10.2214\/AJR.12.9126","volume":"200","author":"K Leung","year":"2013","unstructured":"Leung K, Stamm M, Raja A, Low G (2013) Pheochromocytoma: the range of appearances on ultrasound, CT, MRI, and functional imaging. AJR Am J Roentgenol 200(2):370-378. \nhttps:\/\/doi.org\/10.2214\/AJR.12.9126","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"2044_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2214\/AJR.12.9620","volume":"201","author":"J Patel","year":"2013","unstructured":"Patel J, Davenport MS, Cohan RH, Caoili EM (2013) Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma? AJR Am J Roentgenol 201(1):122-127. \nhttps:\/\/doi.org\/10.2214\/AJR.12.9620","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"2044_CR37","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2214\/AJR.15.15318","volume":"206","author":"N Schieda","year":"2016","unstructured":"Schieda N, Alrashed A, Flood TA, Samji K, Shabana W, McInnes MD (2016) Comparison of Quantitative MRI and CT Washout Analysis for Differentiation of Adrenal Pheochromocytoma From Adrenal Adenoma (2016) Comparison of Quantitative MRI and CT Washout Analysis for Differentiation of Adrenal Pheochromocytoma From Adrenal Adenoma. AJR Am J Roentgenol 206 (6):1141-1148. \nhttps:\/\/doi.org\/10.2214\/AJR.15.15318","journal-title":"AJR Am J Roentgenol"},{"key":"2044_CR38","doi-asserted-by":"publisher","unstructured":"Bessell-Browne R, O\u2019Malley ME (2007) CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v. administration of nonionic contrast material. AJR Am J Roentgenol 188 (4):970-974. \nhttps:\/\/doi.org\/10.2214\/ajr.06.0827","DOI":"10.2214\/ajr.06.0827"},{"issue":"10","key":"2044_CR39","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.crad.2012.02.005","volume":"67","author":"G Low","year":"2012","unstructured":"Low G, Dhliwayo H, Lomas DJ (2012) Adrenal neoplasms. Clinical radiology 67 (10):988-1000. \nhttps:\/\/doi.org\/10.1016\/j.crad.2012.02.005","journal-title":"Clinical radiology"},{"issue":"6","key":"2044_CR40","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.2214\/AJR.10.4547","volume":"194","author":"MA Blake","year":"2010","unstructured":"Blake MA, Cronin CG, Boland GW (2010) Adrenal imaging. AJR American journal of roentgenology 194 (6):1450-1460. \nhttps:\/\/doi.org\/10.2214\/AJR.10.4547","journal-title":"AJR American journal of roentgenology"},{"key":"2044_CR41","doi-asserted-by":"crossref","unstructured":"Lee TH, Slywotzky CM, Lavelle MT, Garcia RA (2002) Cystic pheochromocytoma. Radiographics : a review publication of the Radiological Society of North America, Inc 22 (4):935-940","DOI":"10.1148\/radiographics.22.4.g02jl20935"},{"issue":"11","key":"2044_CR42","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1097\/00007611-199311000-00029","volume":"86","author":"R Munden","year":"1993","unstructured":"Munden R, Adams DB, Curry NS (1993) Cystic pheochromocytoma: radiologic diagnosis. Southern medical journal 86 (11):1302-1305","journal-title":"Southern medical journal"},{"issue":"1","key":"2044_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1749-7922-6-27","volume":"6","author":"JS Hanna","year":"2011","unstructured":"Hanna JS, Spencer PJ, Savopoulou C, Kwasnik E, Askari R (2011) Spontaneous adrenal pheochromocytoma rupture complicated by intraperitoneal hemorrhage and shock. World journal of emergency surgery : WJES 6 (1):27. \nhttps:\/\/doi.org\/10.1186\/1749-7922-6-27","journal-title":"World journal of emergency surgery : WJES"},{"key":"2044_CR44","doi-asserted-by":"publisher","unstructured":"Dong Y, Liu Q (2012) Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T. J Comput Assist Tomogr 36 (4):361-366. \nhttps:\/\/doi.org\/10.1097\/rct.0b013e31825975f8","DOI":"10.1097\/rct.0b013e31825975f8"},{"issue":"2","key":"2044_CR45","doi-asserted-by":"publisher","first-page":"492","DOI":"10.2214\/AJR.05.0370","volume":"187","author":"KY Lee","year":"2006","unstructured":"Lee KY, Oh YW, Noh HJ, Lee YJ, Yong HS, Kang EY, Kim KA, Lee NJ (2006) Extraadrenal paragangliomas of the body: imaging features. AJR Am J Roentgenol 187 (2):492-504. \nhttps:\/\/doi.org\/10.2214\/AJR.05.0370","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"2044_CR46","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1007\/s00330-005-2743-8","volume":"15","author":"R van den Berg","year":"2005","unstructured":"van den Berg R (2005) Imaging and management of head and neck paragangliomas. European radiology 15 (7):1310-1318. \nhttps:\/\/doi.org\/10.1007\/s00330-005-2743-8","journal-title":"European radiology"},{"key":"2044_CR47","doi-asserted-by":"publisher","unstructured":"Otake Y, Aoki M, Imamura N, Ishikawa M, Hashimoto K, Fujiyama R (2006) Aortico-pulmonary paraganglioma: case report and Japanese review. The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi 54 (5):212-216. \nhttps:\/\/doi.org\/10.1007\/bf02670315","DOI":"10.1007\/bf02670315"},{"issue":"1","key":"2044_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1590\/S1807-59322006000100015","volume":"61","author":"RA da Silva","year":"2006","unstructured":"da Silva RA, Gross JL, Haddad FJ, Toledo CA, Younes RN (2006) Primary pulmonary paraganglioma: case report and literature review. Clinics 61 (1):83-86. \nhttps:\/\/doi.org\/10.1590\/S1807-59322006000100015","journal-title":"Clinics"},{"issue":"4","key":"2044_CR49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1053\/j.anndiagpath.2004.04.008","volume":"8","author":"CL Aubertine","year":"2004","unstructured":"Aubertine CL, Flieder DB (2004) Primary paraganglioma of the lung. Annals of diagnostic pathology 8 (4):237-241","journal-title":"Annals of diagnostic pathology"},{"issue":"2","key":"2044_CR50","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.nic.2015.12.005","volume":"26","author":"S Woolen","year":"2016","unstructured":"Woolen S, Gemmete JJ (2016) Paragangliomas of the Head and Neck. Neuroimaging Clin N Am 26 (2):259-278. \nhttps:\/\/doi.org\/10.1016\/j.nic.2015.12.005","journal-title":"Neuroimaging Clin N Am"},{"issue":"9","key":"2044_CR51","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/eci.12495","volume":"45","author":"A Angelousi","year":"2015","unstructured":"Angelousi A, Kassi E, Zografos G, Kaltsas G (2015) Metastatic pheochromocytoma and paraganglioma. Eur J Clin Invest 45 (9):986-997. \nhttps:\/\/doi.org\/10.1111\/eci.12495","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"2044_CR52","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF, Jr., Endocrine Society (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. The Journal of clinical endocrinology and metabolism 99 (6):1915-1942. \nhttps:\/\/doi.org\/10.1210\/jc.2014-1498","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"4","key":"2044_CR53","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2214\/AJR.12.9576","volume":"201","author":"A Raja","year":"2013","unstructured":"Raja A, Leung K, Stamm M, Girgis S, Low G (2013) Multimodality imaging findings of pheochromocytoma with associated clinical and biochemical features in 53 patients with histologically confirmed tumors. AJR Am J Roentgenol 201 (4):825-833. \nhttps:\/\/doi.org\/10.2214\/AJR.12.9576","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"2044_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/RLU.0000000000001504","volume":"42","author":"I Janssen","year":"2017","unstructured":"Janssen I, Wolf KI, Chui CH, Millo CM, Pacak K (2017) Relevant Discordance Between 68\u00a0Ga-DOTATATE and 68\u00a0Ga-DOTANOC in SDHB-Related Metastatic Paraganglioma: Is Affinity to Somatostatin Receptor 2 the Key? Clin Nucl Med 42 (3):211-213. \nhttps:\/\/doi.org\/10.1097\/RLU.0000000000001504","journal-title":"Clin Nucl Med"},{"issue":"9","key":"2044_CR55","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/jnci\/djs188","volume":"104","author":"HJ Timmers","year":"2012","unstructured":"Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Eisenhofer G, King KS, Rao JU, Wesley RA, Adams KT, Pacak K (2012) Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. J Natl Cancer Inst 104 (9):700-708. \nhttps:\/\/doi.org\/10.1093\/jnci\/djs188","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2044_CR56","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/RLU.0b013e318238f550","volume":"37","author":"M Hentschel","year":"2012","unstructured":"Hentschel M, Rottenburger C, Boedeker CC, Neumann HP, Brink I (2012) Is there an optimal scan time for 6-[F-18]fluoro-L-DOPA PET in pheochromocytomas and paragangliomas? Clinical nuclear medicine 37 (2):e24-29. \nhttps:\/\/doi.org\/10.1097\/RLU.0b013e318238f550","journal-title":"Clinical nuclear medicine"},{"issue":"4","key":"2044_CR57","doi-asserted-by":"publisher","first-page":"T135","DOI":"10.1530\/ERC-15-0175","volume":"22","author":"F Castinetti","year":"2015","unstructured":"Castinetti F, Kroiss A, Kumar R, Pacak K, Taieb D (2015) 15 YEARS OF PARAGANGLIOMA: Imaging and imaging-based treatment of pheochromocytoma and paraganglioma. Endocrine-related cancer 22 (4):T135-145. \nhttps:\/\/doi.org\/10.1530\/ERC-15-0175","journal-title":"Endocrine-related cancer"},{"issue":"3","key":"2044_CR58","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/MED.0000000000000330","volume":"24","author":"A Roman-Gonzalez","year":"2017","unstructured":"Roman-Gonzalez A, Jimenez C (2017) Malignant pheochromocytoma-paraganglioma: pathogenesis, TNM staging, and current clinical trials. Curr Opin Endocrinol Diabetes Obes 24 (3):174-183. \nhttps:\/\/doi.org\/10.1097\/MED.0000000000000330","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"2044_CR59","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12022-011-9188-1","volume":"23","author":"G Eisenhofer","year":"2012","unstructured":"Eisenhofer G, Tischler AS, de Krijger RR (2012) Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification. Endocrine pathology 23 (1):4-14. \nhttps:\/\/doi.org\/10.1007\/s12022-011-9188-1","journal-title":"Endocrine pathology"},{"issue":"12","key":"2044_CR60","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1245\/s10434-017-6074-1","volume":"24","author":"M Dhir","year":"2017","unstructured":"Dhir M, Li W, Hogg ME, Bartlett DL, Carty SE, McCoy KL, Challinor SM, Yip L (2017) Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma. Ann Surg Oncol 24 (12):3624-3630. \nhttps:\/\/doi.org\/10.1245\/s10434-017-6074-1","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"2044_CR61","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12022-017-9479-2","volume":"28","author":"YJ Suh","year":"2017","unstructured":"Suh YJ, Choe JY, Park HJ (2017) Malignancy in Pheochromocytoma or Paraganglioma: Integrative Analysis of 176 Cases in TCGA. Endocrine pathology 28 (2):159-164. \nhttps:\/\/doi.org\/10.1007\/s12022-017-9479-2","journal-title":"Endocrine pathology"},{"key":"2044_CR62","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3389\/fendo.2015.00126","volume":"6","author":"MH Costa","year":"2015","unstructured":"Costa MH, Ortiga-Carvalho TM, Violante AD, Vaisman M (2015) Pheochromocytomas and Paragangliomas: Clinical and Genetic Approaches. Front Endocrinol (Lausanne) 6:126. \nhttps:\/\/doi.org\/10.3389\/fendo.2015.00126","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2044_CR63","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.surg.2011.09.024","volume":"150","author":"M Iacobone","year":"2011","unstructured":"Iacobone M, Schiavi F, Bottussi M, Taschin E, Bobisse S, Fassina A, Opocher G, Favia G (2011) Is genetic screening indicated in apparently sporadic pheochromocytomas and paragangliomas? Surgery 150 (6):1194-1201. \nhttps:\/\/doi.org\/10.1016\/j.surg.2011.09.024","journal-title":"Surgery"},{"issue":"31","key":"2044_CR64","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1200\/JCO.2011.34.6353","volume":"29","author":"KS King","year":"2011","unstructured":"King KS, Prodanov T, Kantorovich V, Fojo T, Hewitt JK, Zacharin M, Wesley R, Lodish M, Raygada M, Gimenez-Roqueplo AP, McCormack S, Eisenhofer G, Milosevic D, Kebebew E, Stratakis CA, Pacak K (2011) Metastatic pheochromocytoma\/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29 (31):4137-4142. \nhttps:\/\/doi.org\/10.1200\/JCO.2011.34.6353","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"6","key":"2044_CR65","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.urology.2014.01.007","volume":"83","author":"B Shuch","year":"2014","unstructured":"Shuch B, Ricketts CJ, Metwalli AR, Pacak K, Linehan WM (2014) The genetic basis of pheochromocytoma and paraganglioma: implications for management. Urology 83 (6):1225-1232. \nhttps:\/\/doi.org\/10.1016\/j.urology.2014.01.007","journal-title":"Urology"},{"issue":"3","key":"2044_CR66","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.euf.2015.09.011","volume":"1","author":"N Waingankar","year":"2016","unstructured":"Waingankar N, Bratslavsky G, Jimenez C, Russo P, Kutikov A (2016) Pheochromocytoma in Urologic Practice. Eur Urol Focus 1 (3):231-240. \nhttps:\/\/doi.org\/10.1016\/j.euf.2015.09.011","journal-title":"Eur Urol Focus"},{"issue":"2","key":"2044_CR67","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/107327481101800205","volume":"18","author":"RH Grogan","year":"2011","unstructured":"Grogan RH, Mitmaker EJ, Duh QY (2011) Changing paradigms in the treatment of malignant pheochromocytoma. Cancer control : journal of the Moffitt Cancer Center 18 (2):104-112","journal-title":"Cancer control : journal of the Moffitt Cancer Center"},{"issue":"6","key":"2044_CR68","doi-asserted-by":"publisher","first-page":"R239","DOI":"10.1530\/ERC-16-0542","volume":"24","author":"A Angelousi","year":"2017","unstructured":"Angelousi A, Dimitriadis GK, Zografos G, Nolting S, Kaltsas G, Grossman A (2017) Molecular targeted therapies in adrenal, pituitary and parathyroid malignancies. Endocr Relat Cancer 24 (6):R239-R259. \nhttps:\/\/doi.org\/10.1530\/ERC-16-0542","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2044_CR69","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4081\/oncol.2014.249","volume":"8","author":"AA Mohammed","year":"2014","unstructured":"Mohammed AA, El-Shentenawy AM, Sherisher MA, El-Khatib HM (2014) Target therapy in metastatic pheochromocytoma: current perspectives and controversies. Oncol Rev 8(2):249. \nhttps:\/\/doi.org\/10.4081\/oncol.2014.249","journal-title":"Oncol Rev"},{"issue":"11","key":"2044_CR70","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1210\/jc.2012-2356","volume":"97","author":"M Ayala-Ramirez","year":"2012","unstructured":"Ayala-Ramirez M, Chougnet CN, Habra MA, Palmer JL, Leboulleux S, Cabanillas ME, Caramella C, Anderson P, Al Ghuzlan A, Waguespack SG, Deandreis D, Baudin E, Jimenez C (2012) Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas. J Clin Endocrinol Metab 97(11):4040-4050. \nhttps:\/\/doi.org\/10.1210\/jc.2012-2356","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-019-02044-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00261-019-02044-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-019-02044-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T23:07:20Z","timestamp":1588806440000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00261-019-02044-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["2044"],"URL":"https:\/\/doi.org\/10.1007\/s00261-019-02044-w","relation":{},"ISSN":["2366-004X","2366-0058"],"issn-type":[{"value":"2366-004X","type":"print"},{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,8]]},"assertion":[{"value":"8 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}